Abstract

Adhithya A.*, Adithya Satheesh Kumar*, Sreelakshmi D. R.*, Varsha Vincent*, Soumya R. V., Anjana U. J., Dr. Malini Gopinath, Dr. Prasobh G. R. and Dr. Nithin Manohar R.

ABSTRACT

Peripheral neuropathic pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage. A person’s perception of pain is influenced by their emotional state, the circumstances around how they first experienced the pain and whether they believed it to be a hazardous signal. The most commonly prescribed drugs for neuropathic pain include Pregabalin, Gabapentin and Methylcobalamine along with other drugs for co-morbid conditions. The aim of the study is to evaluate and analyse the prescribing pattern and quality of life in patient with peripheral neuropathic pain. The objectives are To analyse the prescribing pattern of drugs in peripheral neuropathic pain and To assess the improvement in quality of life of patients with peripheral neuropathy. The Prospective observational study was conducted in 77 patients who are diagnosed with Peripheral neuropathic pain in the neurology department. The prescribing pattern of drugs used in peripheral neuropathy was analysed from the prescription. The improvement in the quality of life of the patients were assesed by using NEURO – QOL scale after providing proper patient counselling. The most commonly prescribed drugs for neuropathic pain were found to be Pregabalin, Gabapentin, Lacosamide and Methylcobalamine. A significant increase in quality of life was found in patients after treatment and patient counselling. It was concluded that anti-convulsant like Pregabalin, Gabapentin and Lacosamide along with Methylcobalamine and other drugs for co- morbid conditions are prescribed for peripheral neuropathic pain. There is significant in the QOL scoring in patients after treatment and patient counselling.